Climate Change Data

Glenmark Pharmaceuticals Limited

Climate Impact & Sustainability Data (2021-04 to 2022-03)

Reporting Period: 2021-04 to 2022-03

Environmental Metrics

Total Carbon Emissions:1,19,426 tCO2e/year (Scope 3)
Scope 1 Emissions:14,967 tCO2e/year
Scope 2 Emissions:66,739 tCO2e/year
Scope 3 Emissions:1,19,426 tCO2e/year
Renewable Energy Share:7%
Total Energy Consumption:4,90,705 GJ/year
Water Consumption:4,81,340 KL/year
Waste Generated:1,237 tons/year (Hazardous)
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Ethical and accountable governance
  • Action oriented environmental consciousness
  • Socially relevant and inclusive

Environmental Achievements

  • 6% of our electrical energy derived from renewable sources of energy
  • Energy conservation of 23,902 GJ
  • 29,733 trees planted cumulatively since FY 13
  • Scope 1 emissions stood at 14,967 tCO2e
  • 400 KL of rainwater harvested
  • 1,74,848 KL of wastewater recycled
  • 15,11,061 KL of water saved since FY 14
  • 100% EPR target achieved to recycle/reprocess plastic waste
  • 49% of hazardous waste generated is co-processed

Social Achievements

  • Impacting over 2.6 million lives through CSR initiatives
  • Product stewardship evidenced through Remo® MV and Remo® -Zen MV (cost 53% lesser than competing brands in India), Ryaltris®, Ryaltris®-AZ
  • Nearly 14.5% of total employees are women
  • Zero cases of fatalities and occupational disease in the last 5 years
  • 19,900+ hours of voluntary service offered by our employees in FY22
  • 6,54,730 hours of training

Governance Achievements

  • 27% of board comprised of female board members
  • Average Board meeting attendance is more than 90%
  • 7 non-executive/independent directors
  • Over 80% of Board members have extensive experience in pharmaceutical industry
  • 0 safety incidents of data or cybersecurity breaches
  • Implemented an anti-bribery and anti-corruption policy
  • Established a dedicated ESG Board committee

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Carbon neutral by 2030 (Scope 1 and Scope 2 emissions)
Short-term Goals:
  • Water neutrality by 2025
  • Zero waste to landfill by 2027

Environmental Challenges

  • Delivering commercially successful new products
  • Ensuring product quality
  • Supply chain continuity
  • Product pricing
  • Compliance with relevant laws and regulations
  • Changing global political and economic conditions
  • Compliance with financial reporting and disclosure requirements
  • Compliance with tax laws
  • Compliance with anti-bribery and corruption legislation
  • Potential litigation
  • Sales and marketing litigation
  • Managing environmental, health, safety, and sustainability compliance
  • Information Technology (IT)
  • Revenue concentration
  • Pandemic risk
Mitigation Strategies
  • Created a symbiotic link between our R&D center and our business strategy
  • Thorough Quality Management System (QMS)
  • Robust inventory management and control, thorough supply chain model and periodic monitoring
  • Created important differentiators in our products and promoting them to justify our prices
  • Experienced regulatory staff, regulatory checks and controls
  • Diverse product portfolio and worldwide reach
  • Keep our financial disclosures up to date
  • Legal and tax consultants
  • Comprehensive system to ensure that our values are in line with anti-bribery and anti-corruption rules
  • Clinical tests before launching products
  • Internal dispute resolution staff up to speed on regional laws and regulations
  • All-encompassing system that includes environmental, health, and safety norms and principles
  • Educate our staff about data privacy and malicious cyberattacks
  • Dedicated project management team
  • Enhanced controls, ensured uninterrupted flow of products throughout the pandemic

Supply Chain Management

Supplier Audits: All suppliers covered under ESG self-assessment program; independent third-party assessment for a subset of critical suppliers

Responsible Procurement
  • Supplier Code of Conduct
  • Supplier sustainability protocol aligned to PSCI requirements

Climate-Related Risks & Opportunities

Physical Risks
  • Extreme weather events
  • Water stress
  • Heat stress
  • Sea level rise
Transition Risks
  • Changing policy and regulatory landscape
Opportunities
  • Water efficiency
  • Research on shifting health demographics
  • Resource efficient operations
  • Renewable sources of energy
  • Climate resilient operations
  • Novel sources of partnerships

Reporting Standards

Frameworks Used: GRI Standards: Core option

Certifications: ISO 14001:2015 and ISO 45001:2018 (100% of Indian manufacturing facilities)

Third-party Assurance: DNV GL Business Assurance India Private Limited

UN Sustainable Development Goals

  • Not disclosed

CSR programs aligned to UN SDGs

Sustainable Products & Innovation

  • Remo® MV and Remo® -Zen MV
  • Ryaltris®
  • Ryaltris®-AZ
  • FabiSpray®

Awards & Recognition

  • Best Corporate Foundations award (Glenmark Foundation)
  • Gold Award (Project 'Health on Wheels')
  • Silver Award (COVID indigenous response project)
  • 8th CSR India Awards
  • British Safety Council Award (Goa facility)
  • CII National award for environmental best practices (Goa facility)
  • Gold awards (Indore manufacturing facility and Mahape R&D facility)
  • Apex India Green Leaf Award 2021 (Nalagarh facility)